ROC-101

· AllRock Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ROC-101, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) [Phase 2]

See pricing